Quarterly report pursuant to Section 13 or 15(d)

Share-based compensation

v3.22.1
Share-based compensation
3 Months Ended
Mar. 31, 2022
Share-based compensation  
Share-based compensation

Note 12 Share-based compensation

The following table shows the total share-based compensation expense included in the unaudited consolidated statements of operations (in thousands):

Three months ended

March 31, 

    

2022

    

2021

Research and development

$

2,523

$

2,375

General and administrative

 

3,063

2,959

$

5,586

$

5,334

The following table shows information about share options and options which have a nominal exercise price (similar to restricted stock units (RSUs)) granted:

Three months ended

March 31, 

    

2022

    

2021

Number of options over ordinary shares granted

22,876,464

14,803,056

Weighted average fair value of ordinary shares options

$

0.43

$

0.75

Number of additional options with a nominal exercise price granted

17,688,432

12,663,792

Weighted average fair value of options with a nominal exercise price

$

0.59

$

1.03